Dustin Sjuts

Track

Insider profile

Currently holds a position at Revance Therapeutics Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Commercial Officer, Aesthetics & Therapeutics Revance Therapeutics Inc Dec. 2, 2019 -
Vice President of Strategy and Sales Revance Therapeutics Inc April 2, 2018 - Dec. 2, 2019
Dustin Sjuts's trades of Revance Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
30.82
Quantity 5,000
Value US$154,096
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-19 2024-03-18
S Sale
67,183 +6.1%
244.37
US$2,209,004 		67,183 +6.1% 244.37 US$2,209,004
2024-03-18 2024-03-15
PrS Proposed sale
92,284
178.67
US$4,232,515 		92,284 178.67 US$4,232,515
2023-06-13 2023-06-09
PlS Planned sale
32,575 -3.7%
78.54
US$446,909 		32,575 -3.7% 78.54 US$446,909
2023-06-09 2023-06-09
PrS Proposed sale
5,000
30.82
US$154,096 		5,000 30.82 US$154,096
2023-05-16 2023-05-15
S Sale
21,015 -12.1%
34.55
US$726,003 		21,015 -12.1% 34.55 US$726,003
2023-05-12 2023-05-12
PrS Proposed sale
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-03-09 2023-03-09
S Sale
21,508 -14.8%
31.59
US$679,358 		21,508 -14.8% 31.59 US$679,358
2023-03-09 2023-03-08
PrS Proposed sale
23,000
33.00
US$759,000 		23,000 33.00 US$759,000